Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

CUSIP: 92764N102

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
+3,023,477
Put/Call ratio
66%
SEC-reported price per share
$25.72
Number of holders
191
Value change
-$14,155,763
Number of buys
123
Open additional details 1 more signal available
Number of sells
89
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
171,342,863

Security key

92764N102

Report period

Q1 2022

Institutions

191

Top holders

10

Ownership snapshot

Top reported holders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F Highest disclosed value: $930,211,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SB INVESTMENT ADVISERS (UK) LTD has the largest disclosed position value at $930.21M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Disclosed position value Top 5
SB INVESTMENT ADVISERS (UK) LTD $930.21M
VANGUARD GROUP INC $306.91M
Temasek Holdings (Private) Ltd $231.85M
Capital International Investors $230.52M
BlackRock Finance, Inc. $222.25M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13F
—
denominator unverified
$930,211,000
22,216,644 shares
— 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$306,913,000
7,330,131 shares
— 31 Dec 2021
Temasek Holdings (Private) Ltd
13F
Company
13F
—
denominator unverified
$231,846,000
5,537,291 shares
— 31 Dec 2021
Capital International Investors
13F
Company
13F
—
denominator unverified
$230,518,000
5,505,566 shares
— 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$222,248,000
5,308,049 shares
— 31 Dec 2021
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$163,942,000
3,915,501 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
191
Shares
81,103,450
Rows available
191
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
191
Q1 2022 holders
191
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .